Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-22

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Chartwell RX, LLC's original ANDA for olmesartan medoxomil tablets, establishing a generic version of the antihypertensive medication. This approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)